Preclinical Pharmacology Studies of Anti-AIDS Agents - M. Chadwick

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: Division of Cancer Treatment (NCI)
Type: Research and Development Contracts (N01)
Project #: N01CM087284-002
Application #: 3615961
Study Section

Project Start: 1988-09-15
Project End: 1991-09-14
Budget Start: 1989-10-05
Budget End: 1990-09-14
Support Year
Fiscal Year: 1990
Total Cost
Indirect Cost

Institution

Name: Arthur D. Little, Inc.
Department
Type
DUNS #

City: Cambridge
State: MA
Country: United States
Zip Code: 02140

Related projects


NIH 1991 N01 CM	Preclinical Pharmacology Studies of Anti-AIDS Agents Nomeir, Amin A. / Arthur D. Little, Inc.
NIH 1990 N01 CM	Preclinical Pharmacology Studies of Anti-AIDS Agents Chadwick, M. / Arthur D. Little, Inc.
NIH 1990 N01 CM	Preclinical Pharmacology Studies of Anti-AIDS Agents Nomeir, Amin A. / Arthur D. Little, Inc.
NIH 1989 N01 CM	Preclinical Pharmacology Studies of Anti-AIDS Agents Nomeir, A. / Arthur D. Little, Inc.
NIH 1988 N01 CM	Preclinical Pharmacology Studies of Anti-AIDS Agents Nomeir, A. / Arthur D. Little, Inc.

Publications

Nomeir, A A; McComish, M F; Ferrala, N F et al. (1998) Liquid chromatographic analysis in mouse, dog and human plasma;stability, absorption, metabolism and pharmacokinetics of the anti-HIV agent 2-chloro-5-(2-methyl-5,6-dihydro-1,4-oxathiin-3-yl carboxamido) isopropylbenzoate (NSC 615985, UC84). J Pharm Biomed Anal 17:27-38

Nomeir, A A; McComish, M F; Mongan, A L et al. (1994) Liquid chromatographic analysis, stability and protein binding studies of the anti-HIV agent benzoic acid, 2-chloro-5[[(1-methylethoxy)thioxomethyl]amino]-,1-methylethyl ester. J Pharm Biomed Anal 12:693-8

Comments

Be the first to comment on M. Chadwick's grant